Fusarochromanone
CAS No. 802915-53-3
Fusarochromanone( —— )
Catalog No. M33984 CAS No. 802915-53-3
Fusarochromanone (FC-101) is a mycotoxin produced by Fusarium marcescens with potent antiangiogenic, anticancer and antimalarial activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1074 | In Stock |
|
| 10MG | 1444 | In Stock |
|
| 25MG | 2138 | In Stock |
|
| 50MG | 2762 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFusarochromanone
-
NoteResearch use only, not for human use.
-
Brief DescriptionFusarochromanone (FC-101) is a mycotoxin produced by Fusarium marcescens with potent antiangiogenic, anticancer and antimalarial activities.
-
DescriptionFusarochromanone (FC-101) is a fungal metabolite with potent anti-angiogenic and anti-cancer activity. Fusarochromanone-activated JNK pathway is attributed to induction of reactive oxygen species (ROS).
-
In VitroFusarochromanone (FC101; 10 μM; 24 hours) induces apoptosis and an increase in proportion of cells in the sub-G1 phase in both HaCat and P9-WT cell lines. Fusarochromanone (FC101; 0-1 μM; 24 h) induces the cleavage of both caspase-3 and PARP, a well-known substrate for activated caspases. FC101 does not affect the expression of the anti-apoptotic proteins, Bcl-2, Bcl-XL, Mcl-1, or the pro-apoptotic proteins BAD, BAK, BAX.Fusarochromanone (FC101) exhibits very potent in-vitro growth inhibitory effects (IC50 ranging from 10 nM-2.5 μM) against HaCat (pre-malignant skin), P9-WT (malignant skin), MCF-7 (low malignant breast), MDA-231 (malignant breast), SV-HUC (premalignant bladder), UM-UC14 (malignant bladder), and PC3 (malignant prostate) in a time-course and dose-dependent manner, with the UM-UC14 cells being the most sensitive.Cell Cycle Analysis Cell Line:HaCat and P9-WT cell lines Concentration:10 μM Incubation Time:24 hours Result:Showed cells in the G2 and M phases of the cell cycle for both cell lines.Western Blot Analysis Cell Line:MDA-MB-231 cells Concentration:0.05 μM, 0.1 μM, 0.2 μM, 0.5 μM, 1 μM Incubation Time:24 hours Result:Induced the cleavage of both caspase-3 and PARP.
-
In VivoFusarochromanone (8 mg/kg; IP; 5 days per week; for 3.5 weeks) Is well tolerated, non-toxic, and achieved a 30% reduction in tumor size at a dose of 8 mg/kg/day.Animal Model:SCID Beige mice (CB17/Icr.Cg-PrkdcscidLystbg/Crl) injected with SRB12-p9 cells Dosage:8 mg/kg Administration:IP; 5 days per week; for 3.5 weeks Result:Achieved a 30% reduction in tumor size at a dose of 8 mg/kg/day.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorReactive Oxygen Species
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number802915-53-3
-
Formula Weight292.33
-
Molecular FormulaC15H20N2O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNC1=C2C(=CC=C1C(C[C@H](CO)N)=O)OC(C)(C)CC2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Elahe Mahdavian, et al.Biological activities of fusarochromanone: a potent anti-cancer agent. BMC Res Notes. 2014 Sep 3;7:601.?
molnova catalog
related products
-
Dyngo-4a
Dyngo-4a , a effective dynamin inhibitor, inhibits withDynI (brain), DynI (rec), and DynII (rec) of IC50 of 0.38 μM, 1.1 μM, and 2.3 μM, respectively.
-
Phenyl-ac-Gly-OH
Phenylacetylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. The presence of phenylacetylglycine in urine has been confirmed for dogs rats and mice. However the presence of this compound in human urine is controversial. GC-MS studies have not found this compound while NMR studies claimed to have identified it.
-
Helospectin II
Helospectin II
Cart
sales@molnova.com